In drug development, which phase directly follows in vitro testing?

In drug development, which phase directly follows in vitro testing?

• A. In vivo testing
• B. Preclinical testing
• C. Clinical trials
• D. Post-market surveillance

Answer: (B)

After in vitro testing, the next step is preclinical testing. In vitro studies use isolated cells or biochemical systems to assess basic effects, mechanisms, potency, and initial safety. However, they can’t capture how a drug behaves in a living organism, where absorption, distribution, metabolism, excretion, and systemic toxicity come into play. Preclinical testing fills this gap by conducting in vivo studies in animals to evaluate pharmacokinetics, pharmacodynamics, and safety margins. This stage provides crucial data on how the drug acts in a whole organism and helps establish safe starting doses and risk assessments before moving into human trials. Only after robust preclinical evidence are human clinical trials (Phase I–III) pursued, and post-market surveillance (Phase IV) occurs after approval to monitor long-term safety.

After in vitro testing, the next step is preclinical testing. In vitro studies use isolated cells or biochemical systems to assess basic effects, mechanisms, potency, and initial safety. However, they can’t capture how a drug behaves in a living organism, where absorption, distribution, metabolism, excretion, and systemic toxicity come into play. Preclinical testing fills this gap by conducting in vivo studies in animals to evaluate pharmacokinetics, pharmacodynamics, and safety margins. This stage provides crucial data on how the drug acts in a whole organism and helps establish safe starting doses and risk assessments before moving into human trials. Only after robust preclinical evidence are human clinical trials (Phase I–III) pursued, and post-market surveillance (Phase IV) occurs after approval to monitor long-term safety.